CAS 5807-14-7|1,5,7-Triazabicyclo[4.4.0]dec-5-ene
| Common Name | 1,5,7-Triazabicyclo[4.4.0]dec-5-ene | ||
|---|---|---|---|
| CAS Number | 5807-14-7 | Molecular Weight | 139.20 |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 222.3±23.0 °C at 760 mmHg |
| Molecular Formula | C7H13N3 | Melting Point | 125-130 °C(lit.) |
| MSDS | ChineseUSA | Flash Point | 88.3±22.6 °C |
| Symbol | GHS05 | Signal Word | Danger |
Names
| Name | 1,5,7-Triazabicyclo[4.4.0]dec-5-ene |
|---|---|
| Synonym | More Synonyms |
1,5,7-Triazabicyclo[4.4.0]dec-5-ene BiologicalActivity
| Description | Triazabicyclodecene is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
|---|---|
| Related Catalog | Research Areas >>OthersSignaling Pathways >>Others >>Others |
Chemical & Physical Properties
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 222.3±23.0 °C at 760 mmHg |
| Melting Point | 125-130 °C(lit.) |
| Molecular Formula | C7H13N3 |
| Molecular Weight | 139.20 |
| Flash Point | 88.3±22.6 °C |
| Exact Mass | 139.110947 |
| PSA | 27.63000 |
| LogP | -1.08 |
| Vapour Pressure | 0.1±0.4 mmHg at 25°C |
| Index of Refraction | 1.656 |
| InChIKey | FVKFHMNJTHKMRX-UHFFFAOYSA-N |
| SMILES | C1CN=C2NCCCN2C1 |
Safety Information
| Symbol | GHS05 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H314 |
| Precautionary Statements | P280-P305 + P351 + P338-P310 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | C: Corrosive; |
| Risk Phrases | R34 |
| Safety Phrases | S26-S36/37/39-S45 |
| RIDADR | UN 1759 8/PG 2 |
| WGK Germany | 3 |
| Packaging Group | III |
| Hazard Class | 8 |
| HS Code | 2933599090 |
Customs
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Articles18
More Articles| A block copolymer of zwitterionic polyphosphoester and polylactic acid for drug delivery. Biomater. Sci. 3 , 1105-13, (2015) Polymeric nanoparticles have been widely used as nano-drug delivery systems in preclinical and clinical trials for cancer therapy, and these systems usually need to be sterically stabilized by poly(et... | |
| Up-regulation of miR-21 and miR-23a Contributes to As2 O3 -induced hERG Channel Deficiency. Basic Clin Pharmacol Toxicol. 116 , 516-23, (2015) Arsenic trioxide (As2O3) is used to treat acute pro-myelocytic leukaemia. However, the cardiotoxicity of long QT syndrome restricts its clinical application. Previous studies showed that As2O3 can dam... | |
| Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer. Med. Oncol. 32(1) , 414, (2014) The mammalian peroxiredoxin 2 (Prdx2) is a member of thiol-dependent antioxidant proteins and plays an important role in the progression of colorectal cancer (CRC). The aim of this study was to confir... |
Synonyms
| 2H-Pyrimido[1,2-a]pyrimidine, 1,3,4,6,7,8-hexahydro- |
| MFCD00043003 |
| 1,3,4,6,7,8-hexahydropyrimido[1,2-a]pyrimidine |
| 3,4,6,7,8,9-hexahydro-2h-pyrimido[1,2-a]pyrimidine |
| Triazabicyclodecene |
| EINECS 227-367-1 |
| TBD |
| 1,5,7-Triazabicyclo[4.4.0]dec-5-ene |
| 1,3,4,6,7,8-hexahydro-2H-pyrimido(1,2-a)pyrimidine |
| 1,3,4,6,7,8-Hexahydro-2H-pyrimido[1,2-a]pyrimidine |
| 1,5,7-triazabicyclo-[4.4.0]dec-5-ene |
